Concepedia

Mingyu Sang

MS

Statistics

Publications

1

Citations

14

H-Index

1

Active since

2023

Affiliations

Shandong University(Current)

Mingyu Sang is an author at Shandong University specializing in cancer therapeutics, oncology, and tumor biology.

Top concepts

Publications per year

2023–2023

1

Publications

1

Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway.

Guodong Huang, Xinning Liu, Ting Jiang et al. · PubMed · 2023 · 14 citations · Full text

, , +15

1–1 of 1